Related Experiment Videos
Mitral valve prolapse: a marker for anxiety or overlapping phenomenon?
Psychopathology
|January 1, 1984
Summary
Symptomatic mitral valve prolapse (MVP) patients exhibit higher catecholamine levels and an exaggerated response to isoproterenol, suggesting their symptoms may be linked to catecholamines. This research explores MVP symptom complexity.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Mitral valve prolapse (MVP) is a condition affecting heart valve function.
- The precise mechanisms underlying symptoms in patients with MVP remain incompletely understood.
- Understanding symptom triggers and physiological responses is crucial for patient management.
Purpose of the Study:
- To investigate the frequency and nature of symptoms in patients with symptomatic mitral valve prolapse (MVP).
- To conduct metabolic studies and assess physiological responses to isoproterenol infusions in MVP patients.
- To explore potential links between catecholamine levels, cardiovascular response, and symptom manifestation in MVP.
Main Methods:
- Analysis of symptom data from 313 symptomatic mitral valve prolapse patients.
- Metabolic studies (n=20) including glucose response and hormone levels.
- Pharmacological stress testing with isoproterenol infusions (n=16) to evaluate cardiovascular and symptomatic responses compared to controls.
Main Results:
- Symptom presentation varies by sex, with chest pain more common initially in men and palpitations in women. Women reported more symptoms overall, including fatigue, dyspnea, and arrhythmias.
- MVP patients showed normal thyroid and cortisol levels but elevated glucose and insulin responses to oral glucose.
- Increased 24-hour urinary catecholamine excretion was observed in MVP patients. Isoproterenol infusions induced symptoms and a greater heart rate increase in MVP patients compared to controls.
Conclusions:
- Mitral valve prolapse patients exhibit elevated catecholamine levels and a hyper-response to isoproterenol, suggesting catecholamine mediation of symptoms.
- The complex symptomology in MVP may be related to catecholamine activity, anxiety states, or MVP serving as a marker for these symptoms.
- Further research is needed to elucidate the exact relationship between MVP, catecholamines, and the diverse symptoms experienced by patients.